A CDC report finds that the risk of COVID-19 infection among those fully vaccinated is 0.01%; HHS announce it is designating $4.8 billion to cover COVID-19 testing for uninsured US residents; European Union seeks significant fine for AstraZeneca over breach of vaccine supply contract.
Patients with acute myeloid leukemia (AML) who relapse after first-line treatment face a substantial health care resource utilization (HCRU) and cost burden, according to a poster presented at Virtual ISPOR 2021.
Analyses showed differential brain activity among migraineurs with anxiety compared with those without anxiety and healthy controls.
Recent coverage from Targeted Oncology® highlights how combination therapies are impacting the treatment spectrum for chronic lymphocytic leukemia (CLL).
Between 2014 and 2018, annual diagnoses for HIV in an emergency department (ED) in Hamilton County, Ohio, more than doubled, from 20 to 42.
Abstracts from the ATS 2021 International Conference provided some insight into tactics that could improve the effectiveness of pulmonary rehabilitation programs in patients with chronic obstructive pulmonary disease (COPD).
A new report shows work-related quality of life in general—and also in terms of physical and mental/emotional health—improved when patients began treatment for atopic dermatitis.
The new report, based on more than 80,000 health records, suggests positive airflow pressure therapy can reduce a patient’s risk of infection.
On this episode of Managed Care Cast, we speak with Gregory Harris, MD, MPH, DFAPA, senior medical director for behavioral health at Blue Cross Blue Shield of Massachusetts, about the challenges of meeting the demand for mental health service during the COVID-19 pandemic.
Michelle M Cloutier, MD, is professor emerita at UCONN Health in Farmington, Connecticut, and chair of the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee Expert Panel Working Group.
Optogenics was used to partially restore a blind man’s eyesight; the FDA could soon approve Moderna’s COVID-19 vaccine for use among adolescents; HHS calls for a new investigation into COVID-19’s origins.
A recent analysis of The Environmental Determinants of Diabetes in the Young study found maternal diet has no impact on type 1 diabetes and islet autoimmunity (IA) risk.
Results from Sharecare's Community Well-Being Index show Massachusetts was the healthiest state in 2020 while Mississippi ranked last.
A higher risk of COVID-19–related mortality was found among hospitalized patients with Parkinson disease (PD) than in the general population. Overall inpatient mortality of those with PD was also significantly higher in 2020 than in the year prior.
Some recent oncology news includes research into factors impacting the well-being of childhood cancer survivors; whether COVID-19 accommodations will last post-pandemic; and a possible new therapy for patients with polycythemia vera.
Long-term use of prescription sleep medications by middle-aged women provides no benefit, a new study says.
Sandoz Canada launches its sixth biosimilar, an anticoagulant used to treat deep vein thrombosis, on the Canadian market.
Mount Sinai research released today shows a possible link between excess pericardial fat and greater risk of heart failure, with implications for early intervention and prevention of heart disease.
The CDC is looking into rare reports of myocarditis in teens who received a COVID-19 vaccine; reduced air pollution during lockdowns prevented premature deaths; new COVID-19 cases in the United States fall to a 1-year low.
Results from a genome-wide association study indicate blood clot factors may contribute to the cause of migraine with aura.
Here is some of the latest news in diabetes from our sister publication Pharmacy Times®.
There are no curative treatments for Tangier disease, but gene therapy for ABCA1 has been highlighted as a potential avenue for treating the disease, say the researchers of the paper.
Birth control guidance provided to women taking rheumatoid arthritis therapies is lacking, and other rheumatology news reported across MJH Life Sciences™.
Generalized pustular psoriasis (GPP) may have therapies in a few years; how patients define remission in psoriatic arthritis (PsA).
A literature review sheds light on cancer risk factors and suboptimal screening levels that persist in the United States among certain racial, ethnic, and socioeconomic groups, despite a steady decline in cancer deaths and smoking prevalence.
With a variety of treatments available for chronic lymphocytic leukemia (CLL), a disease that is extremely heterogeneous, clinicians are faced with a challenging task to choose the right treatment for a patient.
Ultrasounds and MRI are both used to monitor inflammation activity in rheumatoid arthritis, but their value in refining future treatment strategies has so far been unknown.
Posters presented at the ATS 2021 International Conference noted some ways clinical characteristics associated with patients with chronic obstructive pulmonary disease (COPD) differ based on different demographics and smoking status.
Patients with sickle cell disease face substantial health care utilization and impaired health-related quality of life (HRQOL).
Because Medicaid has always been a shared program between federal and state governments, there has been wide variation in income limits. Today, 38 states and the District of Columbia have Medicaid expansion.
